{"DataElement":{"publicId":"6732855","version":"1","preferredName":"B Acute Lymphoblastic Leukemia Symptom Diagnosis Timepoint Present Type","preferredDefinition":"The text response that indicates symptom(s) present at the time of diagnosis with B-Cell Acute Lymphoblastic Leukemia.","longName":"B_ALL_SYMP_DX_TP","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"6732832","version":"1","preferredName":"B Acute Lymphoblastic Leukemia Symptom Diagnosis Timepoint Present","preferredDefinition":"The most frequent type of acute lymphoblastic leukemia.  Approximately 75% of cases occur in children under six years of age.  This is a good prognosis leukemia.  In the pediatric age group the complete remission rate is approximately 95% and the disease free survival rate is 70%.  Approximately 80% of children appear to be cured.  In the adult age group the complete remission rate is 60-85%.  (WHO, 2001)_Subjective evidence of disease perceived by the patient._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._A specific point in the time continuum, including those established relative to an event._Being or existing in a specified place or at the specified time.","longName":"6732830v1.0:2762323v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"6732830","version":"1","preferredName":"B Acute Lymphoblastic Leukemia Symptom","preferredDefinition":"The most frequent type of acute lymphoblastic leukemia.  Approximately 75% of cases occur in children under six years of age.  This is a good prognosis leukemia.  In the pediatric age group the complete remission rate is approximately 95% and the disease free survival rate is 70%.  Approximately 80% of children appear to be cured.  In the adult age group the complete remission rate is 60-85%.  (WHO, 2001):Subjective evidence of disease perceived by the patient.","longName":"C8644:C4876","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B Acute Lymphoblastic Leukemia","conceptCode":"C8644","definition":"The most frequent type of acute lymphoblastic leukemia.  Approximately 75% of cases occur in children under six years of age.  This is a good prognosis leukemia.  In the pediatric age group the complete remission rate is approximately 95% and the disease free survival rate is 70%.  Approximately 80% of children appear to be cured.  In the adult age group the complete remission rate is 60-85%.  (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Symptom","conceptCode":"C4876","definition":"Subjective evidence of disease perceived by the patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87648158-91A0-7FAF-E053-F662850A189C","latestVersionIndicator":"Yes","beginDate":"2019-04-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-25","modifiedBy":"ONEDATA","dateModified":"2019-04-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2762323","version":"1","preferredName":"Diagnosis Timepoint Present","preferredDefinition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.:A specific point in the time continuum, including those established relative to an event.:Being or existing in a specified place or at the specified time.","longName":"C15220:C68568:C25626","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Timepoint","conceptCode":"C68568","definition":"A specific point in the time continuum, including those established relative to an event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"510B8A0C-A671-02E3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-07-02","endDate":null,"createdBy":"STURGILLJ","dateCreated":"2008-07-02","modifiedBy":"ONEDATA","dateModified":"2008-07-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008575","version":"1","preferredName":"Symptoms","preferredDefinition":"signs that a person has a condition or disease. Some examples of symptoms are headache, fever, fatigue, nausea, vomiting, and pain(NCI). ","longName":"SM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB883C03-CF97-2540-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-04-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-04-17","modifiedBy":"MSUPLEY","dateModified":"2004-01-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87648158-91AE-7FAF-E053-F662850A189C","latestVersionIndicator":"Yes","beginDate":"2019-04-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-25","modifiedBy":"HARTLEYG","dateModified":"2019-05-01","changeDescription":"PTCL content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6731730","version":"1","preferredName":"B-Cell ALL Symptom Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"6731730v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"5682944","version":"1","preferredName":"Unknown","longName":"5682944","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B0E12-9AE5-79DC-E053-F662850A0B75","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"GDEEN","dateModified":"2023-12-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87646BBD-03BA-7F67-E053-F662850A7414","beginDate":"2019-04-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-25","modifiedBy":"ONEDATA","dateModified":"2019-04-25","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2757951","version":"1","preferredName":"Other","longName":"2757951","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F52A8FB-E278-3426-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Added concept to value meaning. mc 3/20/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87646BBD-03C5-7F67-E053-F662850A7414","beginDate":"2019-04-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-25","modifiedBy":"ONEDATA","dateModified":"2019-04-25","deletedIndicator":"No"},{"value":"Night sweats","valueDescription":"Night Sweats","ValueMeaning":{"publicId":"3055865","version":"1","preferredName":"Night Sweats","longName":"3055865","preferredDefinition":"Nocturnal periods of profuse diaphoresis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Night Sweats","conceptCode":"C3279","definition":"Perspiration experienced nocturnally that is unrelated to environmental temperature.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"83AB1A31-044B-B4FC-E040-BB89AD4361CD","latestVersionIndicator":"Yes","beginDate":"2010-04-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87646BBD-03D0-7F67-E053-F662850A7414","beginDate":"2019-04-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-25","modifiedBy":"ONEDATA","dateModified":"2019-04-25","deletedIndicator":"No"},{"value":"Weight loss","valueDescription":"Weight Loss","ValueMeaning":{"publicId":"2757889","version":"1","preferredName":"Weight Loss","longName":"2757889","preferredDefinition":"A reduction in overall body mass.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Weight Loss","conceptCode":"C3445","definition":"A reduction in total body weight.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D6B6-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"KUMMEROA","dateModified":"2022-07-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87646BBD-03DB-7F67-E053-F662850A7414","beginDate":"2019-04-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-25","modifiedBy":"ONEDATA","dateModified":"2019-04-25","deletedIndicator":"No"},{"value":"Fever","valueDescription":"Fever","ValueMeaning":{"publicId":"4291754","version":"1","preferredName":"Fever","longName":"4291754","preferredDefinition":"Elevation of body temperature above normal due to inflammatory or immune responses.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fever","conceptCode":"C3038","definition":"Elevation of body temperature above normal due to inflammatory or immune responses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-6364-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87646BBD-03E5-7F67-E053-F662850A7414","beginDate":"2019-04-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-25","modifiedBy":"ONEDATA","dateModified":"2019-04-25","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008575","version":"1","preferredName":"Symptoms","preferredDefinition":"signs that a person has a condition or disease. Some examples of symptoms are headache, fever, fatigue, nausea, vomiting, and pain(NCI). ","longName":"SM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB883C03-CF97-2540-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-04-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-04-17","modifiedBy":"MSUPLEY","dateModified":"2004-01-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87646BBD-03A3-7F67-E053-F662850A7414","latestVersionIndicator":"Yes","beginDate":"2019-04-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-25","modifiedBy":"HARTLEYG","dateModified":"2019-05-01","changeDescription":"PTCL Content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6705584","version":"1","longName":"CCG PTCL (Center for Cancer Genomics - Peripheral T Cell Lymphoma)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6705585","version":"1","longName":"PTCL","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Specify B symptoms present at","type":"Preferred Question Text","description":"Specify B symptoms present at diagnosis","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8764A78F-9F48-78F1-E053-F662850A3611","latestVersionIndicator":"Yes","beginDate":"2019-04-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-25","modifiedBy":"HARTLEYG","dateModified":"2019-05-01","changeDescription":"PTCL content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}